Please login to the form below

Not currently logged in
Email:
Password:

counterfeit medicines

This page shows the latest counterfeit medicines news and features for those working in and with pharma, biotech and healthcare.

Merck completes €15m Spanish biotech facility expansion

Merck completes €15m Spanish biotech facility expansion

Simon Sturge, chief operating officer of Merck's biopharma business, said: “The demand for our core portfolio of medicines keeps increasing worldwide. ... s fight against counterfeit medicines.

Latest news

  • The global scourge of counterfeit medicines The global scourge of counterfeit medicines

    Industry also has to consider the damage to its reputation from the corrosive impact of falsified and counterfeit medicines. ... More than half of the 95, 273, 060 counterfeit medicines impounded last year came from India and China.

  • US Senator sets sights on medicine pricing US Senator sets sights on medicine pricing

    prices for medicines, something that was also proposed by the White House earlier this year. ... While proponents of the idea maintain this will help cut drug prices, critics argue it can leave consumers vulnerable to counterfeit and substandard medicines

  • EMA warns on stolen Herceptin EMA warns on stolen Herceptin

    The European Medicines Agency (EMA) last week told healthcare professionals to be on alert after some vials of Roche's Herceptin (trastuzumab) had been stolen in Italy and given false credentials ... The EMA said it does not expect these measures will

  • IFPMA joins campaign against fake medicines IFPMA joins campaign against fake medicines

    In addition to the IFPMA, the campaing's partners include the International Council of Nurses; the International Institute of Research Against Counterfeit Medicines; Medicines for Malaria Venture and the NCD Alliance. ... against providers and

  • AstraZeneca and UCB drawn into Chinese investigations AstraZeneca and UCB drawn into Chinese investigations

    and domestic pharma companies, and is also cracking down on the illicit trade in unregistered, adulterated and counterfeit medicines. ... the total price of the medicines, according to a report on China.org.cn.

More from news
Approximately 4 fully matching, plus 79 partially matching documents found.

Latest Intelligence

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    Economic growth has enabled people to pay out-of-pocket, with regions and cities now funding some newer medicines. ... online sale of counterfeit medicines, as well as an online medicine safety management programme, as part of a larger smart healthcare

  • Business as usual Business as usual

    No advertising complaints were upheld by the Prescription Medicines Code of Practice Authority (PMCPA) - three were upheld in 2014, Raine explained. ... Orphans accounted for a further 11%. Raine flagged up the work of Operation Pangea, the

  • Country report: The healthcare market in China Country report: The healthcare market in China

    Counterfeit medicines. The counterfeit medicines industry continues to proliferate. It is estimated that the combined street value of the products, if sold as genuine goods, stands at $315m. ... In recognition of the growing problem of counterfeit

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Aegate Ltd

    Aegate operates a highly secure authentication and traceability service for the pharmaceutical industry, addressing the need to protect patients from counterfeit, recalled or expired medicines. ... Legislation for falsified medicines.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics